keyword
https://read.qxmd.com/read/38830246/improving-vaccination-documentation-rates-among-patients-with-breast-cancer-through-patient-outreach
#1
JOURNAL ARTICLE
Stephanie Russell, Marilyn J Miller
BACKGROUND: Patients with cancer are at high risk for infection-related morbidity and mortality; vaccinations reduce this burden. In 2021, vaccination documentation rates were low at an academic medical center breast clinic. OBJECTIVES: The purpose of this pilot quality improvement project was to evaluate an education intervention to increase vaccination documentation among patients with breast cancer. METHODS: During a 16-week period, the 4 Pillars™ Practice Transformation Program was implemented...
May 17, 2024: Clinical Journal of Oncology Nursing
https://read.qxmd.com/read/38830234/beliefs-experiences-and-practices-of-lady-health-workers-in-facilitating-breastfeeding-in-rural-communities-in-pakistan
#2
JOURNAL ARTICLE
Nicola Singletary, Zoha Waqar Farooqi
Pakistan has extremely poor breastfeeding indicators: fewer than half of infants under 6 months are exclusively breastfed, only 20% of infants are breastfed within the first hour of life, and nearly half are never fed colostrum. The country's high infant morbidity and mortality is in part due to this suboptimal infant feeding. A network of lady health workers (LHWs) employed by the government facilitate maternal and child health programs, including breastfeeding support in their communities. This study describes LHWs' perspectives and experiences regarding breastfeeding...
June 3, 2024: Qualitative Health Research
https://read.qxmd.com/read/38830208/bioprinted-multi-composition-array-mimicking-tumor-microenvironments-to-evaluate-drug-efficacy-with-multivariable-analysis
#3
JOURNAL ARTICLE
Gihyun Lee, Soo Jee Kim, Je-Kyun Park
Current organ-on-a-chip technologies confront limitations in effectively recapitulating the intricate in vivo microenvironments and accommodating diverse experimental conditions on a single device. Here, we present a novel approach for constructing a multi-composition tumor array on a single microfluidic device, mimicking complex transport phenomena within tumor microenvironments (TMEs) and allowing for simultaneous evaluation of drug efficacy across 12 distinct conditions. The TME array formed by bioprinting on a microfluidic substrate consists of 36 individual TME models, each characterized by one of three different compositions and tested under four varying drug concentrations...
June 3, 2024: Advanced Healthcare Materials
https://read.qxmd.com/read/38830054/the-mediating-effect-of-coping-style-in-the-relationship-between-sleep-quality-and-perceived-cognitive-impairment-among-breast-cancer-patients-a-cross-sectional-study
#4
JOURNAL ARTICLE
Fan Chen, Changzai Li, Jingwen Zhu, Yaning Zhao, Pan Zhang, Jianru Gao, Yuqi Yang, Lin Guo
BACKGROUND: Perceived cognitive impairment is a significant symptom experienced by breast cancer patients and may be affected by sleep quality. Coping styles have potential relevancies with both sleep quality and perceived cognitive impairment. However, the empirical evidence supporting their association among breast cancer patients is limited. OBJECTIVE: This study explored the associations between sleep quality, coping styles, and perceived cognitive impairment and tested the mediating role of coping styles in breast cancer patients...
June 3, 2024: Cancer Nursing
https://read.qxmd.com/read/38830048/primary-human-papillomavirus-testing-versus-co-testing-clinical-outcomes-in-populations-with-different-disease-prevalence
#5
JOURNAL ARTICLE
Shrutikona Das, Nicolas Wentzensen, George F Sawaya, Didem Egemen, Alexander Locke, Walter Kinney, Thomas Lorey, Li C Cheung
Implementation of primary human papillomavirus (HPV) testing has been slow in the US perhaps due to concerns of decreased sensitivity compared with concurrent HPV and cytology testing (cotesting). We used the National Breast and Cervical Cancer Early Detection Program (NBCCEDP) and the Kaiser Permanente of Northern California (KPNC) cohort to quantify potential trade-offs with primary HPV compared with cotesting in four US populations with differing precancer/cancer prevalence. In all settings, cotesting required more lab tests and more colposcopies compared to primary HPV testing...
June 3, 2024: Journal of the National Cancer Institute
https://read.qxmd.com/read/38830008/social-determinants-of-health-and-depressive-symptoms-before-and-after-cancer-diagnosis
#6
JOURNAL ARTICLE
Jessica L Krok-Schoen, Melica Nikahd, Madison Hyer, Ashley S Felix, Timiya S Nolan, Emily A Ridgway-Limle, Menglin Xu, Allison M Quick, Camille Paoletta, Marissa Horn, Elizabeth K Arthur
Despite frequent reports of mental health needs among older women with cancer, depressive symptoms often go unrecognized and untreated, particularly in socially vulnerable survivors. Here, we examined associations of sociodemographic factors and social limitations with depressive symptoms from pre-diagnosis to post-diagnosis in older women diagnosed with breast or gynecological cancer. Using the Surveillance, Epidemiology, and End Results-Medicare Health Outcomes Survey (SEER-MHOS) linked dataset, we used logistic regression to estimate odds ratios (ORs) and 95% confidence intervals (CIs) for associations between sociodemographic factors (race, ethnicity, marital status, rurality) and social limitations (i...
June 3, 2024: Journal of Women & Aging
https://read.qxmd.com/read/38829772/neratinib-stimulates-senescence-of-mammary-cancer-cells-by-reducing-the-levels-of-sirt1
#7
JOURNAL ARTICLE
Wenhuan Li, Peng Fu, Pengfei Shi, Bo Hu, Hai Li
Neratinib, a typical small-molecule, pan-human tyrosine kinase inhibitor (TKI), has been licensed for the treatment of human epidermal growth factor receptor 2 (HER2)-positive breast cancer. However, the underlying pharmacological mechanism is still unknown. In the current study, we report a novel function of Neratinib by showing that its treatment stimulates senescence of the mammary cancer AU565 cells. Our results demonstrate that Neratinib induces mitochondrial injury by increasing mitochondrial reactive oxygen species (ROS) and reducing intracellular adenosine triphosphate (ATP)...
May 31, 2024: Aging
https://read.qxmd.com/read/38829745/synthesis-in-vitro-and-in-silico-studies-of-novel-bis-triazolopyridopyrimidines-from-curcumin-analogues-as-potential-aromatase-agents
#8
JOURNAL ARTICLE
Sobhi Gomha, Abdel-Aziz El-Sayed, Magdi Zaki, Abdulwahed Alrehaily, Hossein Elbadawy, Ahmad Al-Shahri, Saleh Alsenani, Amr Abouzied
This study aims to combat breast cancer, which is a significant health concern for women worldwide. By targeting aromatase, an enzyme crucial in estrogen synthesis, the research focuses on breast cancer cases, emphasizing the importance of hormonal therapy. The innovative approach of this study involves the synthesis of novel bis-triazolopyridopyrimidines, designed to amplify the combined pharmacological advantages of the pyridopyrimidine and 1,2,4-triazole structures known for their aromatase inhibition and anti-cancer capabilities...
June 3, 2024: Chemistry & Biodiversity
https://read.qxmd.com/read/38829727/celecoxib-augments-paclitaxel-induced-immunogenic-cell-death-in-triple-negative-breast-cancer
#9
JOURNAL ARTICLE
Xiaohui Qian, Huang Yang, Ziqiang Ye, Bingqiang Gao, Zhefeng Qian, Yuan Ding, Zhengwei Mao, Yang Du, Weilin Wang
Triple-negative breast cancer (TNBC) is a highly aggressive malignancy that lacks effective targeted therapies. Inducing immunogenic cell death (ICD) in tumor cells represents a promising strategy to enhance therapeutic efficacy by promoting antitumor immunity. Paclitaxel (PTX), a commonly used chemotherapy drug for TNBC, can induce ICD; however, the resulting immunogenicity is limited. Thus, there is an urgent need to explore strategies that improve the effectiveness of ICD in TNBC by incorporating immunoregulatory agents...
June 3, 2024: ACS Nano
https://read.qxmd.com/read/38829692/health-related-quality-of-life-by-type-of-breast-surgery-in-women-with-primary-breast-cancer-prospective-longitudinal-cohort-study
#10
JOURNAL ARTICLE
Kim Gulis, Julia Ellbrant, Pär-Ola Bendahl, Tor Svensjö, Lisa Rydén
BACKGROUND: Health-related quality of life and patient-related outcome measures for patients with cancer have gained increased interest over the last decade. However, few prospective studies with longitudinal data evaluated health-related quality of life in patients with breast cancer. This study aimed to investigate how health-related quality of life changed from the time of diagnosis to 1 year after breast cancer surgery for the main surgical techniques. METHODS: This prospective longitudinal single-centre study included patients with primary breast cancer diagnosed in 2019-2020 who underwent surgery...
May 8, 2024: BJS Open
https://read.qxmd.com/read/38829686/dux4-is-a-common-driver-of-immune-evasion-and-immunotherapy-failure-in-metastatic-cancers
#11
JOURNAL ARTICLE
Jose Mario Bello Pineda, Robert K Bradley
Cancer immune evasion contributes to checkpoint immunotherapy failure in many patients with metastatic cancers. The embryonic transcription factor DUX4 was recently characterized as a suppressor of interferon-γ signaling and antigen presentation that is aberrantly expressed in a small subset of primary tumors. Here, we report that DUX4 expression is a common feature of metastatic tumors, with ~10-50% of advanced bladder, breast, kidney, prostate, and skin cancers expressing DUX4. DUX4 expression is significantly associated with immune cell exclusion and decreased objective response to PD-L1 blockade in a large cohort of urothelial carcinoma patients...
June 3, 2024: ELife
https://read.qxmd.com/read/38829582/early-evaluation-of-risk-stratification-and-clinical-outcomes-for-patients-with-advanced-breast-cancer-through-combined-monitoring-of-baseline-circulating-tumor-cells-and-dna
#12
JOURNAL ARTICLE
Qiang Zhang, Zheng Cai, Lorenzo Gerratana, Andrew A Davis, Paolo D'Amico, Akhil Chawla, Saya Jacob, Youbin Zhang, Jianhua Jiao, Weijun Qin, Carolina Reduzzi, Lisa Flaum, Ami Shah, William Gradishar
PURPOSE: Early evaluation of tumor heterogeneity related to metastasis and outcomes is a major challenge in the management of advanced BCa in the clinic. Here we introduce the value of baseline CTCs and ctDNA to early differentiate clinical stages, tumor heterogeneity, and prognosis. EXPERIMENTAL DESIGN: We enrolled 254 stage IV and 38 stage III BCa patients and examined the baseline levels of CTCs, CTC-clusters, and plasma ctDNA before initiating therapies. Outcome including PFS, and OS were evaluated...
June 3, 2024: Clinical Cancer Research
https://read.qxmd.com/read/38829577/role-of-microsurgical-tumor-burden-reduction-in-patients-with-breast-cancer-brain-metastases-considering-molecular-subtypes-a-two-center-volumetric-survival-analysis
#13
JOURNAL ARTICLE
Jacopo Bellomo, Anna Maria Zeitlberger, Luis Padevit, Vittorio Stumpo, Meltem Gönel, Jorn Fierstra, Nathalie Nierobisch, Regina Reimann, Isabell Witzel, Michael Weller, Emilie Le Rhun, Oliver Bozinov, Luca Regli, Marian Christoph Neidert, Carlo Serra, Stefanos Voglis
BACKGROUND: Advancements in metastatic breast cancer (BC) treatment have enhanced overall survival (OS), leading to increased rates of brain metastases (BM). This study analyzes the association between microsurgical tumor reduction and OS in patients with BCBM, considering tumor molecular subtypes and perioperative treatment approaches. METHODS: Retrospective analysis of surgically treated patients with BCBM from two tertiary brain tumor Swiss centers. The association of extent of resection (EOR), gross-total resection (GTR) achievement, and postoperative residual tumor volume (RV) with OS and intracranial progression-free survival (IC-PFS) was evaluated using Cox proportional hazard model...
June 3, 2024: Journal of Neuro-oncology
https://read.qxmd.com/read/38829506/pooled-analysis-of-neocarh-and-neocart-trials-patient-reported-outcomes-in-patients-with-early-stage-breast-cancer-receiving-platinum-based-or-anthracycline-based-neoadjuvant-chemotherapy
#14
RANDOMIZED CONTROLLED TRIAL
Ciqiu Yang, Peiyong Li, Yitian Chen, Junqiu Zheng, Xiaoqi Zhang, Hong-Fei Gao, Liulu Zhang, Kun Wang
PURPOSE: Anthracycline-based or platinum-based neoadjuvant chemotherapy belongs to the standard treatment for early-stage breast cancer (EBC) that is either triple-negative or human epidermal growth factor receptor 2 positive (HER2 +). Currently, there is a paucity of data comparing their impact on health-related quality of life (HRQoL). METHODS: Triple-negative or HER2 + EBC from our two prospective randomized controlled trials, neoCARH and neoCART, were divided into two groups based on the neoadjuvant chemotherapy regimens they received: anthracycline-based or platinum-based group...
June 3, 2024: Supportive Care in Cancer
https://read.qxmd.com/read/38829299/validation-of-a-clinical-breast-cancer-risk-assessment-tool-combining-a-polygenic-score-for-all-ancestries-with-traditional-risk-factors
#15
JOURNAL ARTICLE
Brent Mabey, Elisha Hughes, Matthew Kucera, Timothy Simmons, Brooke Hullinger, Holly J Pederson, Lamis Yehia, Charis Eng, Judy Garber, Monique Gary, Ora Gordon, Jennifer R Klemp, Semanti Mukherjee, Joseph Vijai, Kenneth Offit, Olufunmilayo I Olopade, Sandhya Pruthi, Allison Kurian, Mark E Robson, Pat W Whitworth, Tuya Pal, Sarah Ratzel, Susanne Wagner, Jerry S Lanchbury, Katherine Johansen Taber, Thomas P Slavin, Alexander Gutin
PURPOSE: We previously described a combined risk score (CRS) that integrates a multiple-ancestry polygenic risk score (MA-PRS) with the Tyrer-Cuzick (TC) model to assess breast cancer (BC) risk. Here, we present a longitudinal validation of CRS in a real-world cohort. METHODS: This study included 130,058 patients referred for hereditary cancer genetic testing and negative for germline pathogenic variants in BC-associated genes. Data were obtained by linking genetic test results to medical claims (median follow-up 12...
May 28, 2024: Genetics in Medicine: Official Journal of the American College of Medical Genetics
https://read.qxmd.com/read/38829261/nanomedicine-targeting-cuproplasia-in-cancer-labile-copper-sequestration-using-polydopamine-particles-blocks-tumor-growth-in-vivo-through-altering-metabolism-and-redox-homeostasis
#16
JOURNAL ARTICLE
Javier Bonet-Aleta, Miguel Encinas-Gimenez, Miku Oi, Aidan T Pezacki, Victor Sebastian, Alba de Martino, Ana Martín-Pardillos, Pilar Martin-Duque, Jose L Hueso, Christopher J Chang, Jesus Santamaria
Copper plays critical roles as a metal active site cofactor and metalloallosteric signal for enzymes involved in cell proliferation and metabolism, making it an attractive target for cancer therapy. In this study, we investigated the efficacy of polydopamine nanoparticles (PDA NPs), classically applied for metal removal from water, as a therapeutic strategy for depleting intracellular labile copper pools in triple-negative breast cancer models through the metal-chelating groups present on the PDA surface. By using the activity-based sensing probe FCP-1, we could track the PDA-induced labile copper depletion while leaving total copper levels unchanged and link it to the selective MDA-MB-231 cell death...
June 3, 2024: ACS Applied Materials & Interfaces
https://read.qxmd.com/read/38829178/extracellular-vesicle-proteins-as-breast-cancer-biomarkers-mass-spectrometry-based-analysis
#17
REVIEW
Raju Bandu, Jae Won Oh, Kwang Pyo Kim
Extracellular vesicles (EVs) are membrane-surrounded vesicles released by various cell types into the extracellular microenvironment. Although EVs vary in size, biological function, and components, their importance in cancer progression and the potential use of EV molecular species to serve as novel cancer biomarkers have become increasingly evident. Cancer cells actively release EVs into surrounding tissues, which play vital roles in cancer progression and metastasis, including invasion and immune modulation...
June 2024: Proteomics
https://read.qxmd.com/read/38829141/endoscopic-bilateral-nipple-sparing-mastectomy-via-a-single-axillary-incision-with-immediate-pre-pectoral-implant-based-breast-reconstruction
#18
JOURNAL ARTICLE
Ze Huang, Zongyan Li, Xiaofang Zhong, Qingyu Yang, Lina Wei, Dongyuan Li, Haiyan Li
Oncoplastic breast surgery, with its focus on improving cosmetic outcomes while maintaining oncological safety, has fundamentally transformed the landscape of breast cancer surgical treatment, giving rise to an array of techniques for breast reconstruction. Nipple-sparing mastectomy (NSM) with immediate implant-based breast reconstruction (IBBR) has emerged as a cornerstone in managing early breast cancer. Aligned with the principles of minimally invasive surgery, recent years have witnessed the widespread integration of endoscopic approaches in breast surgery, encompassing procedures like endoscopic breast-conserving surgery (E-BCS) and endoscopic nipple-sparing mastectomy (E-NSM), among others...
May 17, 2024: Journal of Visualized Experiments: JoVE
https://read.qxmd.com/read/38828981/unreported-source-of-interference-with-the-bispectral-index-during-liposuction-a-case-report
#19
JOURNAL ARTICLE
Vasyl Katerenchuk, Alexandre Calçada, Ana Correia Batista, Lisbete Cordeiro
Incorrect bispectral index (BIS) values have been reported due to interference with this monitoring system. We report a case of a 46-year-old woman who underwent liposuction and breast lipofilling, where we observed a misinterpretation by the BIS algorithm that has not yet been reported. Concurrently with abdominal and thigh liposuction, an increase in the BIS value was observed. The importance of examining electroencephalogram (EEG) and density spectral array (DSA) readings during liposuction procedures is highlighted in this case report, extending our observations beyond just the numerical BIS value, which is not always reliable...
June 1, 2024: A&A Practice
https://read.qxmd.com/read/38828938/ecog-acrin-eaz171-prospective-validation-trial-of-germline-predictors-of-taxane-induced-peripheral-neuropathy-in-black-women-with-early-stage-breast-cancer
#20
JOURNAL ARTICLE
Bryan P Schneider, Fengmin Zhao, Tarah J Ballinger, Sofia F Garcia, Fei Shen, Shamsuddin Virani, David Cella, Casey Bales, Guanglong Jiang, Lisa Hayes, Nadia Miller, Jayanthi Srinivasiah, Erica M Stringer-Reasor, Ami Chitalia, Andrew A Davis, Della F Makower, Jason Incorvati, Melissa A Simon, Edith P Mitchell, Angela DeMichele, Kathy D Miller, Joseph A Sparano, Lynne I Wagner, Antonio C Wolff
PURPOSE: Black women experience higher rates of taxane-induced peripheral neuropathy (TIPN) compared with White women when receiving adjuvant once weekly paclitaxel for early-stage breast cancer, leading to more dose reductions and higher recurrence rates. EAZ171 aimed to prospectively validate germline predictors of TIPN and compare rates of TIPN and dose reductions in Black women receiving (neo)adjuvant once weekly paclitaxel and once every 3 weeks docetaxel for early-stage breast cancer...
June 3, 2024: Journal of Clinical Oncology
keyword
keyword
406
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.